Empagen-M XR Tablets 5/1000mg

Product Overview

Product Form: Tablets
Pack Size: 30 tablets
Prescription Required: Yes

Empagen-M XR Tablets 5/1000mg Details

Empagen-M XR Tablets contain a unique formulation of 5mg of Empagliflozin and 1000mg of Metformin, designed to effectively manage type 2 diabetes. Empagliflozin works by increasing glucose excretion in urine, while Metformin helps decrease glucose production in the liver and improves insulin sensitivity in the body. This combination offers a comprehensive approach to controlling blood sugar levels in diabetic patients.

Empagen-M XR Tablets Uses

- Helps lower blood sugar levels in patients with type 2 diabetes - Supports weight management in diabetic individuals - Reduces the risk of cardiovascular events in diabetic patients - Improves overall glycemic control - Enhances insulin sensitivity in the body

How To Use Empagen-M XR Tablets

Take Empagen-M XR Tablets as directed by your healthcare provider. Usually, the recommended dosage is one tablet once a day, with or without food. Swallow the tablet whole with a glass of water. Follow a healthy diet and exercise regimen while taking this medication for optimal results.

Adverse Effects

Common side effects of Empagen-M XR Tablets may include gastrointestinal discomfort such as nausea, diarrhea, or stomach upset. In some cases, individuals may experience urinary tract infections or increased urination. If you notice any severe or persistent side effects, consult your doctor immediately.

Important Warnings & Precautions

It is essential to monitor your blood sugar levels regularly while taking Empagen-M XR Tablets to ensure proper diabetes management. Inform your healthcare provider about any existing medical conditions or medications you are currently taking before starting this treatment. Avoid consuming alcohol excessively while on this medication, as it may affect blood sugar control. Pregnant or nursing women should consult a healthcare professional before using Empagen-M XR Tablets.

Tags:

Diabetes management, Empagliflozin, Metformin, Blood sugar control, Type 2 diabetes